Skip to main content
. 2016 Jan 19;6(1):e009237. doi: 10.1136/bmjopen-2015-009237

Figure 3.

Figure 3

Prevalence of prescribing of ICS in the year before, during and after pregnancy in women with a live or stillbirth during 2004–2010 for women prescribed ≥1 prescription for an asthma medication during ≥1 of the time periods of interest (ICS, inhaled corticosteroid; LABA, long-acting β-2-agonist; SABA, short-acting β-2-agonist).